Telepathology Development and Stakeholder Perspectives in China: Cross-Sectional Survey
Telepathology in China grew significantly from 2018 to 2023, with high satisfaction among both pathologists and patients. For sustained development, a multilevel approach is essential: improving system usability, implementing supportive policies (eg, funding and insurance coverage), and conducting targeted promotion of its proven benefits. This integrated strategy is key to making telepathology a sustainable solution for equitable diagnostic access nationwide.
Authors
- Fangfang Cui
- Xianying He (ORCID: https://orcid.org/0000-0001-6918-9997)
- Linlin Wang
Institutions
- Beijing Academy of Artificial Intelligence (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Shanghai Artificial Intelligence Laboratory (CN)
Publication Details
- Journal
- JMIR Medical Informatics
- Published
- 2026-03-16
- DOI
- https://doi.org/10.2196/83514
- Primary Topic
- AI in cancer detection
- Type
- article
- Field-Weighted Citation Impact
- 0.00